A phase 1 study of S-237648 for treatment of Obesity
Latest Information Update: 05 Feb 2019
At a glance
- Drugs S 237648 (Primary)
- Indications Obesity
- Focus Adverse reactions
Most Recent Events
- 05 Feb 2019 New trial record
Latest Information Update: 05 Feb 2019